A large pharmaceutical company was among the LPs as the firm reached the first close of its $190m fifth fund.

The Israel-based company, backed by investors including Yaskawa Electric, intends to spend the proceeds on sales, marketing and product development.

The GE-backed medical device company has now raised more than $60m in funding across four rounds.

Ral protein research could lead to novel therapeutics against cancer.

The two foundations have signed a formal affiliation agreement.

Oxtex and Brainomix have secured cash from the $2m fund set up earlier this year.

Queensland Brain Institute researchers are inspired by shrimp to detect the disease.

Imperial Innovations led the investment round of the oncology company.

Phamaceutical company Takeda has invested $25m and entered into a strategic partnership with biotech company BioMotiv.